Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.
Read More…
Industry, Sector and Symbol
Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Phone980-299-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.37 billion
Profitability
Miscellaneous
Employees5,900
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Albemarle (NYSE:ALB) Frequently Asked Questions
What is Albemarle's stock symbol?
Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."
How often does Albemarle pay dividends? What is the dividend yield for Albemarle?
Albemarle announced a quarterly dividend on Wednesday, July 24th. Stockholders of record on Friday, September 13th will be paid a dividend of $0.3675 per share on Tuesday, October 1st. This represents a $1.47 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date of this dividend is Thursday, September 12th. View Albemarle's Dividend History.
How were Albemarle's earnings last quarter?
Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Wednesday, August, 7th. The specialty chemicals company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.41 by $0.14. The specialty chemicals company had revenue of $885.05 million for the quarter, compared to analysts' expectations of $893.50 million. Albemarle had a net margin of 16.01% and a return on equity of 15.71%. The company's revenue was up 3.7% compared to the same quarter last year. During the same period last year, the firm posted $1.36 EPS. View Albemarle's Earnings History.
When is Albemarle's next earnings date?
What guidance has Albemarle issued on next quarter's earnings?
Albemarle issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $6.25-6.65 for the period, compared to the Thomson Reuters consensus estimate of $6.18. The company issued revenue guidance of $3.65-3.85 billion, compared to the consensus revenue estimate of $3.67 billion.
What price target have analysts set for ALB?
17 brokerages have issued 12 month price objectives for Albemarle's shares. Their forecasts range from $39.50 to $128.00. On average, they expect Albemarle's stock price to reach $88.1765 in the next twelve months. This suggests a possible upside of 47.1% from the stock's current price. View Analyst Price Targets for Albemarle.
What is the consensus analysts' recommendation for Albemarle?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 3 sell ratings, 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.
Has Albemarle been receiving favorable news coverage?
Media stories about ALB stock have trended positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Albemarle earned a news sentiment score of 2.5 on InfoTrie's scale. They also gave media headlines about the specialty chemicals company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View News Stories for Albemarle.
Are investors shorting Albemarle?
Albemarle saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 16,612,100 shares, an increase of 5.4% from the June 30th total of 15,762,300 shares. Based on an average trading volume of 1,460,000 shares, the days-to-cover ratio is currently 11.4 days. Currently, 15.8% of the shares of the company are sold short. View Albemarle's Current Options Chain.
Who are some of Albemarle's key competitors?
What other stocks do shareholders of Albemarle own?
Who are Albemarle's key executives?
Albemarle's management team includes the folowing people:
- Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
- Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
- Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
- Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
- Mr. David Ryan, VP of Corp. Strategy & Investor Relations
Who are Albemarle's major shareholders?
Albemarle's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.02%), BlackRock Inc. (7.84%), BlackRock Inc. (7.83%), Primecap Management Co. CA (5.45%), Baillie Gifford & Co. (2.53%) and Bank of New York Mellon Corp (2.11%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.
Which institutional investors are selling Albemarle stock?
ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Jennison Associates LLC, Jennison Associates LLC, Robecosam AG, United Services Automobile Association, Bank of America Corp DE, Zurcher Kantonalbank Zurich Cantonalbank and Janus Henderson Group PLC. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.
Which institutional investors are buying Albemarle stock?
ALB stock was purchased by a variety of institutional investors in the last quarter, including Primecap Management Co. CA, Sterling Capital Management LLC, BlackRock Inc., BlackRock Inc., Invesco Ltd., AXA, Nuveen Asset Management LLC and Grantham Mayo Van Otterloo & Co. LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.
How do I buy shares of Albemarle?
Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Albemarle's stock price today?
One share of ALB stock can currently be purchased for approximately $59.95.
How big of a company is Albemarle?
Albemarle has a market capitalization of $6.35 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.
What is Albemarle's official website?
How can I contact Albemarle?
Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]
MarketBeat Community Rating for Albemarle (NYSE ALB)
MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.
